Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Autism
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-08-06; most recent amendment 2025-04-04.
Trial Details
NCT Number NCT05003960
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Autism
Enrollment 15 participants
Start Date 2022-01-23
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-08